Bruker (BRKRP) Operating Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | - | - | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.17% |
| Dec 31, 2025 | -7.52% |
| Sep 30, 2025 | -21.41% |
| Jun 30, 2025 | -20.68% |
| Mar 31, 2025 | 14.16% |
| Dec 31, 2024 | -9.34% |
| Sep 30, 2024 | -4.95% |
| Jun 30, 2024 | -2.11% |
| Mar 31, 2024 | 9.11% |
| Dec 31, 2023 | -0.55% |
| Sep 30, 2023 | 12.50% |
| Jun 30, 2023 | 12.05% |
| Mar 31, 2023 | 26.35% |
| Dec 31, 2022 | 6.57% |
| Sep 30, 2022 | 20.68% |
| Jun 30, 2022 | 15.92% |
| Mar 31, 2022 | 20.74% |
| Dec 31, 2021 | 10.27% |
| Sep 30, 2021 | 19.79% |
| Jun 30, 2021 | 33.22% |
| Mar 31, 2021 | 21.25% |
| Dec 31, 2020 | 9.79% |
| Sep 30, 2020 | 23.56% |
| Jun 30, 2020 | 3.70% |
| Mar 31, 2020 | 1.53% |
| Dec 31, 2019 | 21.47% |
| Sep 30, 2019 | 78.10% |
| Jun 30, 2019 | 8.61% |
| Mar 31, 2019 | 15.26% |
| Dec 31, 2018 | 11.77% |
| Sep 30, 2018 | 17.01% |
| Jun 30, 2018 | 2.33% |
| Mar 31, 2018 | 25.58% |
| Dec 31, 2017 | 19.44% |
| Sep 30, 2017 | -3.18% |
| Jun 30, 2017 | 9.82% |
| Mar 31, 2017 | 1.79% |
| Dec 31, 2016 | 7.45% |
| Sep 30, 2016 | 4.13% |
| Jun 30, 2016 | -12.02% |
| Mar 31, 2016 | 5.76% |
| Dec 31, 2015 | 6.50% |
| Sep 30, 2015 | -6.42% |
| Jun 30, 2015 | -3.57% |
| Mar 31, 2015 | -10.79% |